Detalhe da pesquisa
1.
Transforming primary human hepatocytes into hepatocellular carcinoma with genetically defined factors.
EMBO Rep;
23(6): e54275, 2022 06 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35437924
2.
Exploring the effect of Wuzhi capsule on the pharmacokinetics of regorafenib and its main metabolites in rat plasma using liquid chromatography-tandem mass spectrometry.
J Sep Sci;
47(5): e2300923, 2024 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38466147
3.
Evaluating linezolid dose regimens against methicillin-resistant Staphylococcus aureus based on renal function in populations with different body weight.
J Clin Pharm Ther;
47(12): 2162-2169, 2022 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36053892
4.
Assessment of micafungin loading dosage regimens against Candida spp. in ICU patients by Monte Carlo simulations.
Eur J Clin Pharmacol;
76(5): 695-702, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32047965
5.
Predictable Resistance and Overall Survival of Gemcitabine/Cisplatin by Platelet Activation Index in Non-Small Cell Lung Cancer.
Med Sci Monit;
24: 8655-8668, 2018 Nov 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30498189
6.
Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors.
Int J Clin Pharmacol Ther;
54(8): 587-96, 2016 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27191765
7.
A pharmacokinetic/pharmacodynamic analysis of a standard voriconazole regimen in different CYP2C19 genotypes by Monte Carlo simulation.
Pharmazie;
70(5): 306-9, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26062298
8.
Evaluation of omadacycline regimens for community-acquired bacterial pneumonia patients infected with Staphylococcus Aureus by pharmacokinetic/pharmacodynamic analysis.
J Chemother;
: 1-8, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38650393
9.
Cost-effectiveness analysis of tislelizumab plus chemotherapy as the first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma in China.
PLoS One;
19(5): e0302961, 2024.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38748691
10.
A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma.
J Oncol;
2023: 5925935, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36844874
11.
Population Pharmacokinetics of Tacrolimus in Pediatric Patients With Umbilical Cord Blood Transplant.
J Clin Pharmacol;
63(3): 298-306, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36196568
12.
Dose-sparing effect of lapatinib co-administered with a high-fat enteral nutrition emulsion: preclinical pharmacokinetic study.
PeerJ;
11: e16207, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37842056
13.
Population Pharmacokinetics of Anlotinib, a Multiple Receptor Tyrosine Kinase Inhibitor, in Chinese Patients With Malignant Tumors.
J Clin Pharmacol;
63(7): 830-837, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37016894
14.
Correlation of gene expression profiles to identify pancreatic cancer cell lines that best model primary human tumors.
Transl Cancer Res;
12(4): 980-991, 2023 Apr 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37180676
15.
Population pharmacokinetics and toxicity correlation analysis of free and liposome-encapsulated doxorubicin in Chinese patients with advanced breast cancer.
Cancer Chemother Pharmacol;
92(3): 181-192, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37378676
16.
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective.
Tumori;
108(1): 33-39, 2022 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33511911
17.
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factor.
Ann Transl Med;
10(2): 43, 2022 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35282046
18.
Underlying mechanism of sorafenib resistance in hepatocellular carcinoma: a bioinformatics study based on validated resistance-related genes.
J Gastrointest Oncol;
12(4): 1895-1904, 2021 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34532137
19.
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial.
BMJ Open;
10(12): e038867, 2020 12 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33371020
20.
Predicted effect of ticagrelor on the pharmacokinetics of dabigatran etexilate using physiologically based pharmacokinetic modeling.
Sci Rep;
10(1): 9717, 2020 06 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32546773